May IgG4-related Disease Be Reactivated by SARS-CoV-2 Infection?
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Zhang P, Wu Q, Xu X, Chen M Front Immunol. 2024; 15:1303589.
PMID: 38455056 PMC: 10917890. DOI: 10.3389/fimmu.2024.1303589.
Idiopathic sclerosing dacryoadenitis.
Butterfield S, Silkiss R J Ophthalmic Inflamm Infect. 2023; 13(1):43.
PMID: 37723320 PMC: 10506976. DOI: 10.1186/s12348-023-00365-y.
References
1.
Kobak S
. The Perfect Storm: A Rheumatologist's Point of View on COVID-19 Infection. Curr Rheumatol Rev. 2020; 17(2):141-152.
DOI: 10.2174/1573397116666201029155105.
View
2.
Kucharz E
. Should coronavirus disease 2019 concern rheumatologists?. Pol Arch Intern Med. 2020; 130(7-8):655-661.
DOI: 10.20452/pamw.15366.
View
3.
Chen Y, Dong Y, Cai S, Ye C, Dong L
. Clinical characteristics of IgG4-RD patients infected with COVID-19 in Hubei, China. Semin Arthritis Rheum. 2020; 50(4):559-563.
PMC: 7228889.
DOI: 10.1016/j.semarthrit.2020.04.015.
View
4.
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y
. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395(10223):497-506.
PMC: 7159299.
DOI: 10.1016/S0140-6736(20)30183-5.
View
5.
Della-Torre E, Lanzillotta M, Strollo M, Ramirez G, Dagna L, Tresoldi M
. Serum IgG4 level predicts COVID-19 related mortality. Eur J Intern Med. 2021; 93:107-109.
PMC: 8461218.
DOI: 10.1016/j.ejim.2021.09.012.
View